000 | 01530 a2200409 4500 | ||
---|---|---|---|
005 | 20250513110719.0 | ||
264 | 0 | _c19970401 | |
008 | 199704s 0 0 eng d | ||
022 | _a1073-2322 | ||
024 | 7 |
_a10.1097/00024382-199701000-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMclntyre, R C | |
245 | 0 | 0 |
_aSelective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. _h[electronic resource] |
260 |
_bShock (Augusta, Ga.) _cJan 1997 |
||
300 |
_a36-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDimaprit _xpharmacology |
650 | 0 | 4 |
_aEndotoxins _xpharmacology |
650 | 0 | 4 |
_aLung Diseases _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
650 | 0 | 4 | _aPulmonary Circulation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xmetabolism |
650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
650 | 0 | 4 |
_aReceptors, Histamine H2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Purinergic P2 _xmetabolism |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aSheridan, B | |
700 | 1 | _aAgrafojo, J | |
700 | 1 | _aFullerton, D A | |
773 | 0 |
_tShock (Augusta, Ga.) _gvol. 7 _gno. 1 _gp. 36-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00024382-199701000-00004 _zAvailable from publisher's website |
999 |
_c8981247 _d8981247 |